Literature DB >> 34350362

The "Nano" World in Photodynamic Therapy.

Huang-Chiao Huang1, Tayyaba Hasan1,2.   

Abstract

Photodynamic Therapy (PDT) is an externally activated, photochemistry-based approach that generates cytotoxic reactive molecular species (RMS), which kill or modulate biological targets. PDT provides unique opportunities for applications of nanotechnology where light activation can trigger both direct RMS-mediated cytotoxic activity and the release of contents within the nanoconstructs (Figure 1). This process allows several species, working via different mechanisms and molecular targets to be activated or released in the right place and time, thus providing a distinctive approach to combination therapy. With advances in the development of miniaturized, even biodegradable, light sources and delivery systems, exciting possibilities of anatomical reach with PDT are being made possible. This brief article introduces aspects of interfaces of PDT and nanotechnology but, due to space constraints, makes no attempt to be a comprehensive review.

Entities:  

Year:  2014        PMID: 34350362      PMCID: PMC8329842     

Source DB:  PubMed          Journal:  Austin J Nanomed Nanotechnol        ISSN: 2381-8956


  63 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents.

Authors:  Jonathan F Lovell; Cheng S Jin; Elizabeth Huynh; Honglin Jin; Chulhong Kim; John L Rubinstein; Warren C W Chan; Weiguo Cao; Lihong V Wang; Gang Zheng
Journal:  Nat Mater       Date:  2011-03-20       Impact factor: 43.841

Review 3.  Liposomal delivery of photosensitising agents.

Authors:  Bin Chen; Brian W Pogue; Tayyaba Hasan
Journal:  Expert Opin Drug Deliv       Date:  2005-05       Impact factor: 6.648

4.  Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy.

Authors:  Sanjay Anand; Clara Wilson; Tayyaba Hasan; Edward V Maytin
Journal:  Cancer Res       Date:  2011-08-01       Impact factor: 12.701

5.  Using cellular mechanisms to develop effective combinations of photodynamic therapy and targeted therapies.

Authors:  Tayyaba Hasan
Journal:  J Natl Compr Canc Netw       Date:  2012-10-01       Impact factor: 11.908

Review 6.  Cancer nanotechnology: opportunities and challenges.

Authors:  Mauro Ferrari
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

7.  Vascular targeted photodynamic therapy for localized prostate cancer.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2008

8.  Photodynamic therapy with decacationic [60]fullerene monoadducts: effect of a light absorbing electron-donor antenna and micellar formulation.

Authors:  Rui Yin; Min Wang; Ying-Ying Huang; Huang-Chiao Huang; Pinar Avci; Long Y Chiang; Michael R Hamblin
Journal:  Nanomedicine       Date:  2013-12-10       Impact factor: 5.307

9.  Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells.

Authors:  A K Sinha; S Anand; B J Ortel; Y Chang; Z Mai; T Hasan; E V Maytin
Journal:  Br J Cancer       Date:  2006-07-25       Impact factor: 7.640

10.  Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.

Authors:  E Reddi; C Zhou; R Biolo; E Menegaldo; G Jori
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

View more
  1 in total

1.  Intratumoral Photosensitizer Delivery and Photodynamic Therapy.

Authors:  Chen-Hua Ma; Jeffrey Yang; Jenna L Mueller; Huang-Chiao Huang
Journal:  Nano Life       Date:  2021-06-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.